Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is comparing iloperidone with placebo for people with Schizophrenia. Participants receive iloperidone or placebo and complete study visits and assessments.
This observational study is following people with Smoking Cessation, Nicotine Addiction, or Schizophrenia to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This observational study is following people with Psychosis or Mental Disorder to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This study is looking at care and outcomes for people with Schizophrenia or schizoaffective disorder. Some participants may receive iTBS, then Sham instead of the study treatment, and direct benefit is not guaranteed.
This study is comparing Cannabidiol oral solution with placebo for people with Early Psychosis. Participants receive Cannabidiol oral solution or placebo and complete study visits and assessments.
This study is looking at care and outcomes for people with Treatment Resistant Psychosis or Psychosis. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
This study is looking at care and outcomes for people with Transcranial Magnetic Stimulation Repetitive or Schizophrenia. Some participants may receive Sham stimulation instead of the study treatment, and direct benefit is not guaranteed.
This study is looking at whether psychoeducation can help people with Autism Spectrum Disorder or Schizophrenia Disorder. Participants receive a study treatment and complete follow-up visits and assessments.
This observational study is following people with Schizophrenia Disorder to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
This study is comparing Neuronavigation-guided individualized iTBS with Control group: ordinary drug treatment for people with Schizophrenia or Transcranial Magnetic Stimulation. Participants receive Neuronavigation-guided individualized iTBS or Control group: ordinary drug treatment and complete study visits and assessments.
This study is looking at care and outcomes for people with Schizophrenia or Cognitive Impairment. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
This study is comparing VV119 Placebo （in healthy adult subjects） with placebo for people with Schizophrenia. Participants receive VV119 Placebo （in healthy adult subjects） or placebo and complete study visits and assessments.
This study is looking at test the inital efficacy of a brief mobile intervention targeting biased thinking for people with Schizophrenia or Clinical High Risk for Psychosis. Participants take part in Mobile Intervention for Biased Thinking and complete follow-up assessments.
This study is looking at whether Online Motivation Enhancing Intervention can help people with Schizophrenia Prodromal, SCHIZOPHRENIA 1, or Psychosis. Participants take part in Online Motivation Enhancing Intervention and complete follow-up assessments.
This study is looking at evaluate the dose levels, safety, and drug levels of KarXT intramuscular injection in participants with Schizophrenia. Participants receive a study treatment and complete follow-up visits and assessments.
This observational study is following people with Schizophrenia to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This observational study is following people with Schizophrenia to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This study is looking at whether LY03020 can help people with Schizophrenia or Alzheimer's Disease Psychosis. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at provide an effective repetitive transcranial magnetic stimulation (rTMS) treatment for depressive symptoms in patients with schizophrenia for people with Schizophrenia and Related Disorders. Some participants may receive Sham rTMS stimulation instead of the study treatment, and direct benefit is not guaranteed.
This study is looking at whether cognitive behavioural therapy can help people with Clinical High Risk for Psychosis or Ultra High Risk for Psychosis. Participants take part in cognitive behavioural therapy and complete follow-up assessments.
This study is looking at care and outcomes for people with Psychosis, First Episode Psychosis, or Psychotic Episode. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
This study is looking at whether a digital support tool can help people with SCHIZOPHRENIA 1, Schizotypal Disorder, or Post Traumatic Stress Symptoms. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at care and outcomes for people with Schizophrenia or Hallucinations, Auditory. Some participants may receive Control Group (SCZ+/AH-) instead of the study treatment, and direct benefit is not guaranteed.
This study is looking at whether psychoeducation can help people with Psychosis or Schizophrenic. Participants take part in the therapy or support program and complete follow-up questionnaires or assessments.
This study is looking at whether Intervention can help people with psychosis. Participants take part in Intervention and complete follow-up assessments.